Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].

Al-Chalabi A, Shaw PJ, Young CA, Morrison KE, Murphy C, Thornhill M, Kelly J, Steen IN, Leigh PN; UKMND-LiCALS.

BMC Neurol. 2011 Sep 21;11:111. doi: 10.1186/1471-2377-11-111.

2.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206. Review.

PMID:
13129806
3.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH.

Cochrane Database Syst Rev. 2002;(2):CD001447. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD001447.

PMID:
12076411
4.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001447. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD001447.

PMID:
17253460
5.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Moore DH.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001447. doi: 10.1002/14651858.CD001447.pub3. Review.

PMID:
22419278
6.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Moore DH.

Cochrane Database Syst Rev. 2001;(4):CD001447. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD001447.

PMID:
11687111
7.

Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease.

Beauverd M, Mitchell JD, Wokke JH, Borasio GD.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD002064. doi: 10.1002/14651858.CD002064.pub3. Review.

PMID:
23152212
8.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Moore DH.

Cochrane Database Syst Rev. 2000;(2):CD001447. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD001447.

PMID:
10796796
9.

Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.

Mitchell JD, Wokke JH, Borasio GD.

Cochrane Database Syst Rev. 2002;(3):CD002064. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD002064.

PMID:
12137643
10.

Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.

Dalbello-Haas V, Florence JM, Krivickas LS.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005229. doi: 10.1002/14651858.CD005229.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD005229.

PMID:
18425913
11.

Creatine for amyotrophic lateral sclerosis/motor neuron disease.

Pastula DM, Moore DH, Bedlack RS.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD005225. doi: 10.1002/14651858.CD005225.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD005225.

PMID:
20556761
12.

Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.

Mitchell JD, Wokke JH, Borasio GD.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD002064. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD002064.

PMID:
17943766
13.

Creatine for amyotrophic lateral sclerosis/motor neuron disease.

Pastula DM, Moore DH, Bedlack RS.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD005225. doi: 10.1002/14651858.CD005225.pub3. Review.

PMID:
23235621
14.

[Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].

Kollewe K, Dengler R, Petri S.

Nervenarzt. 2008 Jun;79(6):653-61. doi: 10.1007/s00115-007-2403-0. Review. German.

PMID:
18210046
15.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
16.
17.
18.

Riluzole and ALS therapy.

Hugon J.

Wien Med Wochenschr. 1996;146(9-10):185-7. Review.

PMID:
8873431
19.

Riluzole, neuroprotection and amyotrophic lateral sclerosis.

Cheah BC, Vucic S, Krishnan AV, Kiernan MC.

Curr Med Chem. 2010;17(18):1942-199. Review.

PMID:
20377511
20.

Pharmacological treatment of ALS.

M√ľnch C, Ludolph AC.

Neurol Neurochir Pol. 2001;35(1 Suppl):41-50. Review.

PMID:
11732279
Items per page

Supplemental Content

Write to the Help Desk